| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MAVERICK CAPITAL LTD | 7.8% | +52% | $26,429,649 | +$8,900,576 | 8,363,813 | +51% | Maverick Capital, Ltd. | 30 Jun 2025 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.9% | -83% | $7,895,181 | -$48,317,346 | 1,004,476 | -86% | Wellington Management Group LLP | 30 May 2025 |
As of 30 Sep 2025, 171 institutional investors reported holding 96,588,463 shares of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT). This represents 90% of the company’s total 107,228,372 outstanding shares.
The largest institutional shareholders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) together control 76% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 16% | 17,687,772 | 0% | 0.71% | $57,662,137 |
| MAVERICK CAPITAL LTD | 7.9% | 8,468,344 | +1.2% | 0.37% | $27,606,801 |
| BlackRock, Inc. | 6.6% | 7,114,371 | -4.2% | 0% | $23,192,850 |
| VANGUARD GROUP INC | 6.4% | 6,892,204 | +13% | 0% | $22,468,585 |
| MPM BIOIMPACT LLC | 3.6% | 3,903,381 | +0.01% | 2.1% | $12,725,022 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3.6% | 3,843,333 | -7.2% | 0.38% | $12,529,266 |
| MORGAN STANLEY | 3.4% | 3,647,039 | +15% | 0% | $11,889,347 |
| MILLENNIUM MANAGEMENT LLC | 3.3% | 3,570,391 | +52% | 0.01% | $11,639,475 |
| Monaco Asset Management SAM | 2.7% | 2,892,261 | +539% | 3.5% | $9,428,771 |
| Newtyn Management, LLC | 2.3% | 2,502,863 | +25% | 1% | $8,159,333 |
| D. E. Shaw & Co., Inc. | 2% | 2,189,750 | +121% | 0.01% | $7,138,585 |
| JPMORGAN CHASE & CO | 2% | 2,097,033 | +74% | 0% | $6,836,329 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 1,914,554 | -5.7% | 0% | $6,242,766 |
| TWO SIGMA ADVISERS, LP | 1.7% | 1,795,751 | +20% | 0.01% | $5,854,148 |
| STATE STREET CORP | 1.6% | 1,745,310 | -10% | 0% | $5,689,711 |
| CITADEL ADVISORS LLC | 1.6% | 1,670,927 | +971% | 0% | $5,447,222 |
| TWO SIGMA INVESTMENTS, LP | 1.5% | 1,609,682 | -6.7% | 0.01% | $5,247,563 |
| Balyasny Asset Management L.P. | 1.2% | 1,313,737 | +897% | 0.01% | $4,282,783 |
| GOLDMAN SACHS GROUP INC | 1.2% | 1,271,093 | -19% | 0% | $4,143,763 |
| Prosight Management, LP | 1.2% | 1,267,965 | -20% | 0.99% | $4,133,566 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.99% | 1,061,295 | -3.5% | 0% | $3,461,000 |
| Qube Research & Technologies Ltd | 0.95% | 1,014,358 | -34% | 0% | $3,306,807 |
| AQR CAPITAL MANAGEMENT LLC | 0.81% | 873,247 | +12% | 0% | $2,846,787 |
| TANG CAPITAL MANAGEMENT LLC | 0.79% | 850,000 | 0% | 0.11% | $2,771,000 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.69% | 744,074 | +21% | 0% | $2,425,681 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 459,455 | $1,613,479 | -$62,724 | $3.51 | 11 |
| 2025 Q3 | 96,588,463 | $314,789,901 | +$10,419,402 | $3.26 | 171 |
| 2025 Q2 | 94,974,795 | $232,855,173 | -$147,581,517 | $2.45 | 194 |
| 2025 Q1 | 107,749,040 | $722,024,357 | -$52,696,378 | $6.67 | 233 |
| 2024 Q4 | 109,632,268 | $1,377,359,505 | +$161,902,372 | $12.57 | 222 |
| 2024 Q3 | 92,703,462 | $1,709,382,927 | +$19,027,944 | $18.47 | 189 |
| 2024 Q2 | 91,217,786 | $1,963,307,213 | -$33,485,873 | $21.53 | 176 |
| 2024 Q1 | 92,048,164 | $2,479,705,726 | +$111,013,838 | $26.94 | 183 |
| 2023 Q4 | 89,005,050 | $2,667,733,521 | -$7,076,901 | $29.97 | 192 |
| 2023 Q3 | 89,401,055 | $1,831,770,744 | +$255,347,743 | $20.49 | 174 |
| 2023 Q2 | 76,338,609 | $1,516,884,469 | -$31,879,301 | $19.87 | 162 |
| 2023 Q1 | 78,264,099 | $1,340,378,412 | +$44,795,861 | $17.13 | 161 |
| 2022 Q4 | 75,910,257 | $1,486,203,005 | +$147,925,718 | $19.57 | 167 |
| 2022 Q3 | 69,117,168 | $1,101,781,707 | +$65,989,396 | $15.96 | 159 |
| 2022 Q2 | 64,545,073 | $887,423,123 | +$4,039,525 | $13.76 | 141 |
| 2022 Q1 | 64,321,676 | $1,019,794,471 | +$10,531,491 | $15.86 | 142 |
| 2021 Q4 | 63,097,635 | $1,377,944,582 | +$9,053,118 | $21.83 | 141 |
| 2021 Q3 | 61,977,765 | $1,849,734,470 | -$24,640,220 | $29.89 | 142 |
| 2021 Q2 | 61,808,292 | $2,736,555,111 | -$11,025,172 | $44.29 | 144 |
| 2021 Q1 | 62,013,212 | $2,752,442,865 | -$22,930,130 | $44.37 | 169 |
| 2020 Q4 | 61,952,909 | $3,397,683,589 | +$431,615,785 | $54.84 | 172 |
| 2020 Q3 | 55,227,508 | $1,262,686,245 | +$19,995,693 | $22.86 | 124 |
| 2020 Q2 | 53,342,815 | $1,116,479,207 | +$14,452,216 | $20.93 | 113 |
| 2020 Q1 | 53,304,185 | $743,593,762 | +$12,202,337 | $13.95 | 102 |
| 2019 Q4 | 51,691,134 | $1,176,484,498 | +$87,809,919 | $22.76 | 116 |
| 2019 Q3 | 47,699,668 | $554,996,335 | -$32,553,222 | $11.65 | 91 |
| 2019 Q2 | 49,065,584 | $735,942,854 | +$92,556,483 | $15.00 | 96 |
| 2019 Q1 | 42,874,596 | $750,971,351 | +$16,305,705 | $17.54 | 80 |
| 2018 Q4 | 42,105,260 | $622,102,055 | +$68,806,707 | $14.82 | 86 |
| 2018 Q3 | 36,793,895 | $905,863,120 | +$70,641,682 | $24.62 | 82 |
| 2018 Q2 | 31,064,522 | $605,382,076 | +$63,867,898 | $19.63 | 75 |
| 2018 Q1 | 27,976,061 | $502,091,019 | +$502,091,019 | $18.75 | 55 |